IPDQF
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | -0.01 | $8M | $0 |
| 2025 Q4 | -0.01 | $7M | -$7M |
| 2024 Q2 | -0.00 | $6M | -$7M |
| 2024 Q4 | -0.00 | $6M | -$14M |
| 2023 Q2 | -0.00 | $5M | -$8M |
| 2023 Q4 | -0.01 | $6M | -$9M |
| 2022 Q2 | -0.01 | $6M | -$15M |
| 2022 Q4 | -0.01 | $5M | -$12M |